BioSpace News Archive

Seelos intends to use the net proceeds from the offering for general corporate purposes, to advance the development of its product candidates and the repayment approximately $0.7 million under the convertible promissory note previously issued to Lind Global Asset Management V, LLC.

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”) announced that at a special meeting held today, preliminary results indicate that the stockholders of the Company voted to approve the Company’s previously announced acquisition (the “Merger”) by Biogen Inc., a Delaware corporation (“Biogen”).

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced 510(k) clearance for its Activit-E™ polyethylene for the Vantage® Total Ankle System.

Tyber Medical, a leader in the medical device industry, is pleased to announce that it has received.

The American Cancer Society expanded its impact on pediatric patients with cancer through the launch of ACS PAWS, a pilot grant program that aims to improve the quality of life for hospitalized children with cancer through support from specially trained therapy dogs.

JanOne, the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the Dawson James Securities 8th Annual Investment Conference in Jupiter, Florida.

Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, announced the launch of Water for Injection and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada.

Inimmune announced today that its Chief Operating Officer, Dr. David Burkhart, will give a plenary presentation at the upcoming 17th Vaccine Congress in Glasgow, Scotland September 24-27th.

Lehigh Valley Health Network and its subsidiaries, which include Lehigh Valley Reilly Children’s Hospital, and Children’s Hospital of Philadelphia announced an affiliation agreement that will enhance the care, health outcomes and well-being of families throughout the region.

C2N Diagnostics is marking World Alzheimer’s Day by highlighting the growing international availability of the PrecivityAD2 blood test, a clinical care assay that helps healthcare providers identify amyloid plaques in the brain, which are recognized as key indicators of Alzheimer’s disease.